StockNews.com Begins Coverage on Surmodics (NASDAQ:SRDX)

StockNews.com assumed coverage on shares of Surmodics (NASDAQ:SRDX – Free Report) in a report issued on Thursday. The firm issued a hold rating on the stock. Several other research firms have also issued reports on SRDX. Lake Street Capital restated a hold rating and issued a $43.00 target price on shares of Surmodics in a […]

Leave a Reply

Your email address will not be published.

Previous post Tantech (NASDAQ:TANH) Coverage Initiated by Analysts at StockNews.com
Next post AvePoint (NASDAQ:AVPT) vs. Enfusion (NYSE:ENFN) Head to Head Analysis